Lennox; William Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lennox; William Joseph.The latest application filed is for "indole derivatives and methods for antiviral treatment".

Company Profile

0.17.15

Lennox; William Joseph - South Plainfield NJ US
Lennox; William Joseph - Bedminster NJ US
Lennox; William Joseph - Monsey NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis Grant 8,940,896 - Moon , et al. January 27, 2	2015-01-27
Indole derivatives and methods for antiviral treatment Grant 8,735,414 - MacCoss , et al. May 27, 2	2014-05-27
Carboline derivatives useful in the inhibition of angiogenesis Grant 8,372,860 - Moon , et al. February 12, 2	2013-02-12
Carboline derivatives useful in the inhibition of angiogenesis Grant 8,367,694 - Moon , et al. February 5, 2	2013-02-05
Indole Derivatives And Methods For Antiviral Treatment App 20120184574 - Maccoss; Malcolm ; et al.	2012-07-19
Carboline Derivatives Useful In The Inhibition Of Angiogenesis App 20110160190 - MOON; Young-Choon ; et al.	2011-06-30
Carboline derivatives useful in the treatment of cancer Grant 7,767,689 - Moon , et al. August 3, 2	2010-08-03
Carboline Derivatives Useful In The Inhibition Of Angiogenesis App 20100179132 - Moon; Young-Choon ; et al.	2010-07-15
Carboline Derivatives Useful In The Inhibition Of Angiogenesis App 20100125065 - Moon; Young-Choon ; et al.	2010-05-20
Carboline derivatives useful in the inhibition of angiogenesis Grant 7,601,840 - Moon , et al. October 13, 2	2009-10-13
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Grant 7,585,876 - Bernotas , et al. September 8, 2	2009-09-08
Tetra-Cyclic Carboline Derivatives Useful in the Inhibition of Angiogenesis App 20080182866 - Moon; Young-Choon ; et al.	2008-07-31
Azaindolylalkylamine Derivatives As 5-hydroxytryptamine-6 Ligands App 20080114023 - BERNOTAS; Ronald Charles ; et al.	2008-05-15
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Grant 7,297,705 - Bernotas , et al. November 20, 2	2007-11-20
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Grant 7,022,701 - Cole , et al. April 4, 2	2006-04-04
Carboline derivatives useful in the treatment of cancer App 20050282849 - Moon, Young-Choon ; et al.	2005-12-22
Carboline derivatives useful in the inhibition of angiogenesis App 20050272759 - Moon, Young-Choon ; et al.	2005-12-08
Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands App 20050124603 - Zhou, Ping ; et al.	2005-06-09
Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands Grant 6,903,112 - Zhou , et al. June 7, 2	2005-06-07
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands App 20050020598 - Bernotas, Ronald Charles ; et al.	2005-01-27
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands App 20040209867 - Cole, Derek Cecil ; et al.	2004-10-21
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Grant 6,800,640 - Bernotas , et al. October 5, 2	2004-10-05
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Grant 6,770,642 - Cole , et al. August 3, 2	2004-08-03
Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands Grant 6,767,912 - Zhou , et al. July 27, 2	2004-07-27
Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands App 20040092526 - Zhou, Ping ; et al.	2004-05-13
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands App 20030171395 - Bernotas, Ronald Charles ; et al.	2003-09-11
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands App 20030171353 - Cole, Derek Cecil ; et al.	2003-09-11
Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands App 20020198213 - Zhou, Ping ; et al.	2002-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.